Pharmacy benefits present funds with a unique dilemma. More drugs are available to improve the medical outlook of members and their covered dependents. But funds face a hefty price tag, while pharmacy news can be hard to understand for them.
For example, drug treatments for diabetes continue to rank as the top traditional drug therapy class, based on per member per year (PMPY) costs. But why do diabetic treatments drive costs so significantly when many generics are available?
Our Trends in Pharmacy newsletter provides answers on this topic. You'll also find the latest pharmacy information on these current topics:
Specialty drugs – what type of coverage makes the most sense?
FDA approves high-cost drug/biologic therapies - drugs that treat rare conditions